Concourse Financial Group Securities, Inc. Roivant Sciences Ltd. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$10.17 - $12.5 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$10.36 - $11.74 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$9.87 - $11.8 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$8.38 - $11.58 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$9.76 - $13.19 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$9.76 - $13.19 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$7.09 - $10.08 $0 - $0
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$3.36 - $7.99 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.51 - $4.84 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.81 - $4.84 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.74 - $9.91 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$5.86 - $13.52 $0 - $0

Others Institutions Holding ROIV

# of Institutions

311

Shares Held

508M

Call Options Held

1.26M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.83B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account